Gainers
- Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the press release, Q4 earnings came out 2 days ago.
- Gelesis Holdings (NYSE:GLS) shares increased by 8.94% to $6.7. Trading volume for this security closed at 125.1K, accounting for 27.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $483.8 million.
- Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 8.53% to $2.67. The market value of their outstanding shares is at $81.9 million.
- Cingulate (NASDAQ:CING) stock increased by 7.56% to $1.99. The market value of their outstanding shares is at $22.5 million.
- Adagio Therapeutics (NASDAQ:ADGI) shares rose 6.22% to $4.44. The company's market cap stands at $493.9 million.
- Immix Biopharma (NASDAQ:IMMX) stock increased by 6.08% to $2.18. The market value of their outstanding shares is at $16.5 million.
Losers
- Rezolute (NASDAQ:RZLT) stock decreased by 8.9% to $3.6 during Wednesday's after-market session. Trading volume for this security closed at 3.8 million, accounting for 11575.2% of its average full-day volume over the last 100 days. The company's market cap stands at $56.0 million.
- Apellis Pharmaceuticals (NASDAQ:APLS) shares declined by 7.1% to $49.1. Trading volume for this security closed at 90.4K, accounting for 9.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.7 billion.
- Galera Therapeutics (NASDAQ:GRTX) shares decreased by 6.88% to $2.44. The market value of their outstanding shares is at $65.3 million.
- Aditxt (NASDAQ:ADTX) shares declined by 6.67% to $0.47. Aditxt's trading volume hit 100.0K shares by close, accounting for 7.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $20.9 million.
- Stoke Therapeutics (NASDAQ:STOK) shares decreased by 4.97% to $22.78. Stoke Therapeutics's trading volume hit 131.4K shares by close, accounting for 40.9% of its average volume over the last 100 days. The company's market cap stands at $851.0 million.
- Cara Therapeutics (NASDAQ:CARA) stock decreased by 4.88% to $11.52. The market value of their outstanding shares is at $616.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
